RESMETIROM | N217785 | MADRIGAL PHARMACEUTICALS INC
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 7452882 | Sep 12, 2026 | — | Yes | Yes | — | — |
| 9266861 | Sep 17, 2033 | — | Yes | Yes | — | — |
| 10376517 | Sep 17, 2033 | — | — | — | — | |
| 11564926 | Sep 17, 2033 | — | Yes | Yes | — | |
| 11986481 | Sep 17, 2033 | — | — | — | — | |
| 12377104 | Feb 4, 2045 | — | — | — | — | |
| 12661359Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Jan 28, 2042 | — | — | — | — | |
| 12667575Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Feb 4, 2045 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| NCE | Mar 14, 2029 | Active |